Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Gross Profit (2017 - 2025)

Historic Gross Profit for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $233.0 million.

  • Inspire Medical Systems' Gross Profit rose 1437.0% to $233.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $778.8 million, marking a year-over-year increase of 1455.36%. This contributed to the annual value of $778.8 million for FY2025, which is 1455.36% up from last year.
  • Inspire Medical Systems' Gross Profit amounted to $233.0 million in Q4 2025, which was up 1437.0% from $192.7 million recorded in Q3 2025.
  • In the past 5 years, Inspire Medical Systems' Gross Profit ranged from a high of $233.0 million in Q4 2025 and a low of $34.4 million during Q1 2021
  • Moreover, its 5-year median value for Gross Profit was $127.9 million (2023), whereas its average is $126.4 million.
  • Its Gross Profit has fluctuated over the past 5 years, first skyrocketed by 34423.7% in 2021, then soared by 986.02% in 2025.
  • Quarter analysis of 5 years shows Inspire Medical Systems' Gross Profit stood at $67.2 million in 2021, then soared by 72.14% to $115.7 million in 2022, then soared by 42.08% to $164.5 million in 2023, then increased by 23.88% to $203.7 million in 2024, then grew by 14.37% to $233.0 million in 2025.
  • Its Gross Profit stands at $233.0 million for Q4 2025, versus $192.7 million for Q3 2025 and $182.4 million for Q2 2025.